Abstract
Aggregation cascade for Alzheimer's amyloid‐β peptides, its relevance to neurotoxicity in the course of Alzheimer's disease and experimental methods useful for these studies are discussed. Details of the solid‐phase peptide synthesis and sample preparation procedures for Alzheimer's β‐amyloid fibrils are given. Recent progress in obtaining structural constraints on Aβ‐fibrils from solid‐state NMR and scanning transmission electron microscopy (STEM) data is discussed. Polymorphism of amyloid fibrils and oligomers of the ‘Arctic’ mutant of Aβ(1–40) was studied by 1H,13C solid‐state NMR, transmission electron microscopy (TEM) and atomic force microscopy (AFM), and a real‐time aggregation of different polymorphs of the peptide was observed with the aid of in situ AFM. Recent results on binding of Cu(II) ions and Al–citrate and Al–ATP complexes to amyloid fibrils, as studied by electron paramagnetic resonance (EPR) and solid‐state 27Al NMR techniques, are also presented. Copyright © 2004 John Wiley & Sons, Ltd.
Funding Information
  • Swedish Foundation of International Cooperation in Research and Higher Education (STINT).
  • Swedish Research Council.
  • Swedish Alzheimer's Fund.
  • Foundation to the Memory of J. C. and Seth M. Kempe.

This publication has 125 references indexed in Scilit: